TGFB1 and Miyoshi myopathy: Our findings suggest that neutralizing TGF-β1 or activating the cGAS-STING pathway could restore the expression of the antigen presentation system and immunosuppressive signal in MM cells affected by Tregs, potentially providing therapeutic strategies for MM treatment.